Status:

RECRUITING

Video Assisted Study of Salbutamol Response in Viral Wheezing

Lead Sponsor:

University of Oulu

Conditions:

Wheezing

Eligibility:

All Genders

6-24 years

Brief Summary

The study is video assisted cross-over study evaluating the effect of inhaled salbutamol in wheeze in children 6-24 months old.

Detailed Description

The object of the study is to evaluate the effect of inhaled salbutamol in wheeze in children 6-24 months old. In despite of the lack of evidence of salbutamol, it is considered the gold standard in ...

Eligibility Criteria

Inclusion

  • Wheezing
  • Salbutamol-treatment in emergency department prescribed

Exclusion

  • Need for immediate resuscitation
  • Immediate transfer to ICU
  • Suspicion of pneumonia based on the auscultation finding
  • Suspicion of airway foreign body

Key Trial Info

Start Date :

October 23 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06093152

Start Date

October 23 2023

End Date

December 1 2026

Last Update

February 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Pediatrics, Oulu University Hospital

Oulu, Finland, 90130

Video Assisted Study of Salbutamol Response in Viral Wheezing | DecenTrialz